GB1031364A - Improvements in or relating to 6-hydroxymorphinan derivatives and their production - Google Patents
Improvements in or relating to 6-hydroxymorphinan derivatives and their productionInfo
- Publication number
- GB1031364A GB1031364A GB13478/63A GB1347863A GB1031364A GB 1031364 A GB1031364 A GB 1031364A GB 13478/63 A GB13478/63 A GB 13478/63A GB 1347863 A GB1347863 A GB 1347863A GB 1031364 A GB1031364 A GB 1031364A
- Authority
- GB
- United Kingdom
- Prior art keywords
- oxo
- cis
- prepared
- morphinan
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
6 - Hydroxy - morphinans of the Formula I wherein R represents a hydrogen atom, an alkyl group of not more than 5 carbon atoms, or an alkanoyl group of not more than 6 carbon atoms, R1 represents a hydrogen atom or an aryloxy group, R11 represents a hydrogen or a hydroxyl group, and a double bond may exist between the 7 - and 8 - carbon atoms are prepared by reduction of 6-oxo-morphinans of the Formula II <FORM:1031364/C2/1> <FORM:1031364/C2/2> wherein R111 represents a hydrogen atom, an alkyl group of not more than 5 carbon atoms or an alkanoyl group having not more than 6 carbon atoms and a double bond can exist between the 7- and 8-positions, the reduction being carried out by electrolysis, catalytic hydrogenation, alkali metals in alkanols, amalgams, metal hydrides or the Meerweim-Ponndorf method. Where the a - and b -isomers are both produced they may be isolated by conventional separation techniques. (-) - 3 - hydroxy - 6 - oxo - N - methylmorphinan (cis) is prepared by the action of hydrobromic acid on the corresponding 3-methoxy compound. (-) - 3 - Methoxy - 6 - oxo - N - methyl - D 7-morphinan (cis) is prepared by the action of acetic acid on (-)-3,6-dimethoxy-N-methyl-D 5 8-morphinan (cis). (-) - 3 - Methoxy - 6 - oxo - 14 - hydroxy - N - methylmorphinan (cis) is prepared from thebaine by oxidation to give the 6-oxo-14-hydroxy derivative which is converted to its oxime which on reduction gives 3-methoxy-4,14-dihydroxy - 6 - oxo - N - methyl morphinan. This is etherified to its 4-phenoxy-derivative which is converted to the 6,6-diethyleneoxy-derivative. The 4-phenoxy group is eliminated and the product deketalated to give the desired compound. (-) - 3,14 - Dihydroxy - 6 - oxo - N - methylmorphinan (cis) is prepared by the action of hydrobromic acid on the corresponding 3-methoxy compound. (-) - 3 - Methoxy - 6 - oxo - N - methylmorphinan (trans) is prepared from (-)-3,6-dimethoxy-N-methyl-D 5,8-morphinan by treatment with hydrochloric acid followed by reduction using palladium on carbon. (-) - 3 - Acetyloxy - 6 - oxo - N - methyl - D 7-morphinan (cis) is prepared from (-)-3-methoxy-6 - oxo - N - methyl - D 7 - morphinan (cis) b treatment with aluminium bromide and acetylation with acetic-anhydride and pyridine. (-) - 3 - Acetyloxy - 6 - oxo - N - methyl-morphinan (cis) is prepared by acetylation of the corresponding 3-hydroxy compound.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1425062 | 1962-04-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1031364A true GB1031364A (en) | 1966-06-02 |
Family
ID=11855826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB13478/63A Expired GB1031364A (en) | 1962-04-09 | 1963-04-04 | Improvements in or relating to 6-hydroxymorphinan derivatives and their production |
Country Status (2)
Country | Link |
---|---|
CH (1) | CH438350A (en) |
GB (1) | GB1031364A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8937084B2 (en) | 2012-12-14 | 2015-01-20 | Purdue Pharma L.P. | Nitrogen containing morphinan derivatives and the use thereof |
US8946255B2 (en) | 2012-12-28 | 2015-02-03 | Purdue Pharma L.P. | Substituted morphinans and the use thereof |
US8957084B2 (en) | 2012-12-28 | 2015-02-17 | Purdue Pharma L.P. | 7,8-cyclicmorphinan analogs |
US8980906B2 (en) | 2012-12-14 | 2015-03-17 | Purdue Pharma L.P. | Pyridonemorphinan analogs and biological activity on opioid receptors |
US9340542B2 (en) | 2013-12-26 | 2016-05-17 | Purdue Pharma L.P. | Propellane-based compounds and the use thereof |
-
1963
- 1963-04-04 GB GB13478/63A patent/GB1031364A/en not_active Expired
- 1963-04-08 CH CH448263A patent/CH438350A/en unknown
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8937084B2 (en) | 2012-12-14 | 2015-01-20 | Purdue Pharma L.P. | Nitrogen containing morphinan derivatives and the use thereof |
US8980906B2 (en) | 2012-12-14 | 2015-03-17 | Purdue Pharma L.P. | Pyridonemorphinan analogs and biological activity on opioid receptors |
US9403824B2 (en) | 2012-12-14 | 2016-08-02 | Purdue Pharma L.P. | Pyridonemorphinan analogs and biological activity on opioid receptors |
US8946255B2 (en) | 2012-12-28 | 2015-02-03 | Purdue Pharma L.P. | Substituted morphinans and the use thereof |
US8957084B2 (en) | 2012-12-28 | 2015-02-17 | Purdue Pharma L.P. | 7,8-cyclicmorphinan analogs |
US9388162B2 (en) | 2012-12-28 | 2016-07-12 | Purdue Pharma L.P. | Substituted morphinans and the use thereof |
US9340542B2 (en) | 2013-12-26 | 2016-05-17 | Purdue Pharma L.P. | Propellane-based compounds and the use thereof |
Also Published As
Publication number | Publication date |
---|---|
CH438350A (en) | 1967-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1031364A (en) | Improvements in or relating to 6-hydroxymorphinan derivatives and their production | |
GB1040554A (en) | The manufacture of 3-keto-19-alkyl-steroids | |
US3600403A (en) | Hydrogenation of pyrone compounds | |
GB508944A (en) | Improvements in the manufacture and production of butanediol-1.4 and its derivatives containing two hydroxy groups | |
US3004965A (en) | Process and intermediates for preparing steroidal 17->18 lactones | |
DE2439082A1 (en) | 17 ALPHA-HYDROXY-1,3,5 (10), 15-OESTRATETRAENE AND THE METHOD OF MANUFACTURING IT | |
US3061606A (en) | Delta-4-pregnenolones and method | |
GB1435204A (en) | Cardenolides and process for their manufacture | |
GB1309651A (en) | Process for the preparation of 3-oxo-19 nor-delta 4- steroids via nitrogenous 4,5-secosteroids | |
Barton et al. | Oxidation of ketone acetals by hydride transfer | |
US3132153A (en) | 2-substituted testols-and andrololactones | |
GB1029218A (en) | Process for producing 19-norsteroids and intermediates therefor | |
GB1103982A (en) | Novel 3,5-seco-a-nor-steroid derivatives | |
Shamma et al. | A stereospecific conversion of berberine into (±)-β-hydrastine | |
GB1436670A (en) | Preparation of alpha-6-deoxy-5-oxytetracycline | |
Krakower et al. | Transformations of fusidic acid. III. 17-Oxa-4. alpha., 8,-14-trimethyl-D-homo-18-norandrostanes | |
AT253145B (en) | Process for the preparation of new 1, 2β-methylene-3-ketosteroids | |
ES379193A1 (en) | 01beta-METHYL-19-NORPREGNENE COMPOUNDS | |
Liston et al. | Conformational transmission. Part II. The effect of a 7, 8-double bond on the enol acetylation properties of 3-oxo-5β-steroids | |
GB1279993A (en) | 08-METHYL-Delta<1>,<4>-ANDROSTADIENES AND PROCESS FOR THEIR MANUFACTURE | |
GB1251740A (en) | ||
GB1053214A (en) | ||
GB1235642A (en) | A new oestratriol and a process for its manufacture | |
GB1327745A (en) | Steroid glycosides and a process for their manufacture | |
IE37779B1 (en) | New benzopyran derivatives |